Ogilvy reshuffle sweetens Healthworld
pharmafile | April 14, 2005 | News story | Medical Communications |
The new Ogilvy Healthworld Advertising agency has been launched in the UK following a re-organisation at media communications giant WPP.
The new agency combines Sugar at Ogilvy and Healthworld Advertising London, following the merger of their parent companies earlier this year.
Ogilvy Healthworld Advertising becomes one of the top five healthcare advertising agencies in the UK, employing 35 full-time staff for a client base that includes five of the top ten pharmaceutical companies and three of the top six spending OTC companies.
Ian Dorrian, managing director of Ogilvy Healthworld Advertising, said: "We aim to create a true market leader across OTC, DTC and Rx advertising channels by bringing together two creative and mould-breaking agencies with a wealth of complimentary skills and no client conflicts."
The new agency will have access to its parent company's network of 53 offices in 35 markets, a resource chairman Tim Herman said will give them "an unrivalled geographical reach for true global campaign implementation".
In addition to London-based Ogilvy Healthworld Advertising, Ogilvy Healthworld also has European offices in France, Spain, Switzerland, Germany, Italy, Turkey, Netherlands, Austria, Belgium, Sweden, Denmark, Finland, the Czech Republic and Poland.
The former head of Ogilvy Healthcare Europe Margot James becomes regional president of Ogilvy Healthworld Europe, having previously founded the Shire Health Group, taking it through a 1999 acquisition by WPP.
Chief executive Steven Girgenti provides overall leadership for Ogilvy Healthworld and the company's merger coincided with two new global brand identity account wins.
Ogilvy Healthworld will work with AstraZeneca to develop a new global brand identity for Galida, a treatment for type II diabetes and metabolic syndrome, which has an expected 2007 launch date.
It has also been appointed by the global marketing team at Roche to develop and implement brand strategy and marketing communications for breast cancer treatment Herceptin in all markets except the US and Japan.
